Advertisement
On Sunday, November 9, 2008, John Podesta, who is leading President ElectBarack Obama's transition team, told Fox News(http://www.foxnews.com/story/0,2933,449164,00.html):
Advertisement
"We're looking at -- again, in virtually every agency to see where we canmove forward, whether that's on energy transformation, on improving healthcare, on stem cell research.
There's a lot that the president can do using his executive authoritywithout waiting for congressional action, and I think we'll see the presidentdo that ..."
Mr. Schissler commented, "Because of this interview, there seems to be arejuvenated and heightened awareness to stem cells and the philosophy changethat is anticipated from our President Elect. It is my hope that, through aseries of communicative letters to shareholders and families alike, that CBAIcan provide valuable information from both a macroeconomic perspective, aswell as a direct relation to the individual."
"I am often asked the question: 'What does this mean for Cord BloodAmerica?'" Mr. Schissler said. "Families ask us: 'What does this mean for myfamily, should I store stem cells, what are the differences between embryonicand adult stem cells, and what does the research mean to our medical communityand our economy?'"
"We believe the letter that was posted today and which can be accessed athttp://www.cordblood-america.com will help answer some of these questions,"Cord Blood America's CEO said. "In summary, we believe that an infusion ofcapital into stem cell research and development will lead to more therapiesbeing commercialized, a higher percentage of families benefiting from thesetherapies and, subsequently, a higher percentage of families choosing to storestem cells. We believe this is a significant positive for both stem cellcompanies and our shareholders."
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company ofCorCell, which facilitates umbilical cord blood stem cell preservation forexpectant parents and their children. Its mission is to be the most respectedstem cell preservation company in the industry. Collected through a safe andnon-invasive process, cord blood stem cells offer a powerful and potentiallylife-saving resource for treating a growing number of ailments, includingcancer, leukemia, blood, and immune disorders. To find out more about CordBlood America, Inc. (OTC Bulletin Board: CBAI), visit our website athttp://www.corcell.com. For investor information, visithttp://www.cordblood-america.com.
Forward-Looking Statements
Some statements made in this press release are forward-looking statements,which are made pursuant to the safe harbor provisions of the PrivateSecurities Litigation Reform Act of 1995. We use words such as "anticipate,""believe," "expect," "future," "intend," "plan," and similar expressions toidentify forward-looking statements. These statements including those relatedto the growth of the industry, new stem cell treatments, and the Company'sperformance, are only predictions and are subject to certain risks,uncertainties and assumptions. Additional risks are identified and describedin the Company's public filings with the Securities and Exchange Commission.Statements made herein are as of the date of this press release and should notbe relied upon as of any subsequent date. The Company's past performance isnot necessarily indicative of its future performance. The Company does notundertake, and the Company specifically disclaims any obligation to update anyforward-looking statements to reflect occurrences, developments, events, orcircumstances after the date of such statement.CONTACT: Paul Knopick E & E Communications 949/707-5365 [email protected]
SOURCE Cord Blood America, Inc.
